PatternsRadar
Sign in

DCALDishman Carbogen Amcis Limited

NSEASM Stage IBand 10%
115.57INR-2.96 (-2.50%)Close · 20 Nov 2026
13 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,812 CrMarket cap
—P/E (TTM)
53.1%Delivery

Filings & corporate actions

39 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 15 Feb 2027
Estimate: filed 34–46 days after quarter end, last 5 times
Dividend
₹0.20 per share · last 12 Sept 2019
2026
  • 13 NovresultsResults · Q2 FY27 · consolidated and standalone-19.5%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026-2.5%NSE
  • 14 AugresultsResults · Q1 FY27 · consolidated and standalone-7.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-0.3%NSE
  • 19 MayresultsResults · Q4 FY26 · consolidated and standalone+12.2%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+1.2%NSE
  • 3 FebresultsResults · Q3 FY26 · consolidated and standalone-7.8%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-4.8%NSE

Reaction to results · all yearsrose on day 0 in 15 of 41 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2713 Nov 2026-19.5%——12.6×
Q1 FY2714 Aug 2026-7.8%-9.1%-14.4%12.5×
Q4 FY2619 May 2026+12.2%+5.0%-9.7%18.7×
Q3 FY263 Feb 2026-7.8%-8.5%-28.1%4.3×
Q2 FY264 Nov 2025-10.0%-17.4%-23.2%3.6×
Q1 FY2612 Aug 2025+5.0%+11.1%+8.6%0.5×
Q4 FY2521 May 2025+11.5%+20.8%+9.5%23.8×
Q3 FY2513 Feb 2025-11.1%-3.3%-4.7%2.0×
Q2 FY2514 Nov 2024+7.0%+12.0%+34.7%7.8×
Q1 FY2514 Aug 2024+2.0%+11.5%+16.2%0.4×
Q4 FY2431 May 2024-4.3%+1.7%+5.5%1.9×
Q3 FY2415 Feb 2024-0.1%+19.6%+8.9%2.4×
Q2 FY249 Nov 2023-3.1%+0.2%-3.6%1.4×
Q1 FY2410 Aug 2023-0.1%-6.2%+0.4%1.8×
Q4 FY2324 May 2023+1.4%+5.7%+24.4%0.8×
Q3 FY2311 Feb 2023+13.5%+26.2%+48.7%29.2×
Q2 FY2312 Nov 2022+6.2%-5.6%-8.2%2.6×
Q1 FY2310 Aug 2022+0.3%+4.5%+0.5%1.3×
Q4 FY2211 May 2022-22.6%-20.9%-10.7%5.7×
Q3 FY224 Feb 2022-4.3%-12.5%-21.8%0.9×
Q2 FY2229 Oct 2021-2.9%+1.7%+12.9%0.5×
Q1 FY2213 Aug 20210.0%-17.2%+2.0%0.9×
Q4 FY2112 May 2021+1.9%+17.8%+30.0%1.0×
Q3 FY2112 Feb 2021-0.1%-3.7%+0.1%0.6×
Q2 FY2113 Nov 2020-2.0%+9.7%+20.8%2.3×
Q1 FY219 Sept 2020-3.7%-0.3%-0.2%2.1×
Q4 FY204 Jun 2020-2.2%+67.0%+72.5%4.7×
Q3 FY2024 Jan 2020-2.3%-10.6%+5.2%1.0×
Q2 FY2024 Oct 2019-8.0%-17.6%-6.4%3.1×
Q1 FY2014 Aug 2019-5.5%-15.5%-7.8%0.5×
Q4 FY1916 May 2019-4.3%+1.0%+8.8%2.1×
Q3 FY1924 Jan 2019-1.6%-7.0%-14.9%1.2×
Q2 FY1923 Nov 2018-0.6%-3.4%-5.4%0.6×
Q1 FY192 Aug 2018+1.1%+3.2%+19.3%2.6×
Q4 FY1725 May 2018+1.8%-4.8%-10.1%1.0×
Q4 FY1825 May 2018+1.8%-4.8%-10.1%1.0×
Q3 FY1830 Jan 2018+0.5%-7.3%-11.3%0.6×
Q3 FY1730 Jan 2018+0.5%-7.3%-11.3%0.6×
Q2 FY1713 Nov 2017-4.4%-7.5%-1.6%1.3×
Q1 FY1813 Nov 2017-4.4%-7.5%-1.6%1.3×
Q2 FY1813 Nov 2017-4.4%-7.5%-1.6%1.3×
Average-1.7%+0.3%+3.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-22.3%
Profit YoY-202.2%
Interest cost YoY-5.5%
Revenue QoQ-25.1%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+2.6%+2.4%+4.8%+6.5%+5.8%+3.8%
Profit——————

Key data

Open116.00
Day range115.00 – 118.99
52-week range115.00 – 274.30
From 52w high-57.9%
RSI (14)27.3
ATR (14)8.70
Volume8.02L
Avg volume (20D)5.73L
Rel volume1.40×
Volatility (1Y)57.0%
Turnover₹9.3Cr
Traded value (NSE)₹9.3Cr
VWAP116.38
SMA 50 / 200153.91 / 174.40
Price band10%

Delivery percentage

Latest · 20 Nov 202653.1%
20-day avg50.0%
1-year avg50.3%
Percentile (own history)57th
Range10.0–100.0%
Sessions2,249

Over the last 20 sessions DCAL settled 50.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.3%. The latest session ranks higher than 57% of the 2,249 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders49.0K · -0.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy709 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.50%-33.17%-17.46%-32.97%-45.45%-53.62%

Valuation

Market cap₹1,812 Cr
Market cap (NSE)₹1,812 Cr
Free-float cap₹737 Cr
P/E (TTM)—
P/E (NSE)168.9
EPS (TTM)-7.39
P/B0.3
Net margin (TTM)-4.2%
Other income / PBT—
ROE-1.8%
Debt / equity0.47
Shares outstanding15.68Cr
Listed21 Sept 2017

Ownership

Promoter59.32%
Promoter Δ QoQ0.00 pp
Public40.68%
FII6.97%
DII1.66%
Pledged8.39%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)719.8851.4677.6507.4
YoY chg+5.5%+18.9%-4.3%-22.3%
Net profit (₹ Cr)(13.0)21.7(57.9)(66.7)
YoY chg-380.1%-49.5%-347.2%-202.2%
Net margin-1.8%2.6%-8.5%-13.2%
EPS-0.831.39-3.69-4.26

Shareholding over time

By quarter

30 Sept 2026 · promoter 59.32% · public 40.68%
30 Sept 2021: promoter 59.32%31 Dec 2021: promoter 59.32%31 Mar 2022: promoter 59.32%30 Jun 2022: promoter 59.32%30 Sept 2022: promoter 59.32%31 Dec 2022: promoter 59.32%31 Mar 2023: promoter 59.32%30 Jun 2023: promoter 59.32%30 Sept 2023: promoter 59.32%31 Dec 2023: promoter 59.32%31 Mar 2024: promoter 59.32%30 Jun 2024: promoter 59.32%30 Sept 2024: promoter 59.32%31 Dec 2024: promoter 59.32%31 Mar 2025: promoter 59.32%30 Jun 2025: promoter 59.32%30 Sept 2025: promoter 59.32%31 Dec 2025: promoter 59.32%31 Mar 2026: promoter 59.32%30 Jun 2026: promoter 59.32%30 Sept 2026: promoter 59.32%
2021-092026-09
  • Promoter
  • Public and others
Promoter
59.32%
Public
40.68%
Promoter change
0.00 pp
Filed
21 Oct 2026
FII
6.97%
DII
1.66%
Promoter pledged
8.39%

Who the public is

Mutual funds
1.41%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
6.96%

+0.10 pp QoQ

Retail ≤ ₹2L
14.90%

-0.08 pp QoQ

HNI > ₹2L
12.81%

+0.47 pp QoQ

NRI
1.08%

+0.01 pp QoQ

Bodies corporate
2.10%

+0.57 pp QoQ

Shareholders
49,048

-0.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Adimans Technologies LLPPromoter · Corporate59.32%
Mukul Mahavir AgrawalIndividual5.50%
Massachusetts Institute Of TechnologyFPI2.28%
Hbm Healthcare Investments (Cayman) LtdFPI2.19%
Hsbc Mutual Fund - Hsbc Flexi Cap FundMutual fund1.41%
Tejas TrivediIndividual1.00%
Deohooti Janmejay VyasPromoter · Individual0.00%
Aditi Janmejay VyasPromoter · Individual0.00%
Arpit Janmejay VyasPromoter · Individual0.00%
Mansi Janmejay VyasPromoter · Individual0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 12 Sept 2019 CSV
Financial yearPaymentsDeclaredAdjusted
FY2019-201₹0.20₹0.20
Ex-dateRecord dateDeclaredAdjusted
12 Sept 2019—₹0.20₹0.20

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
9
7 open-market of the newest 9
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
16 Feb 2023Nikunj DesaiRelativeBuy554₹55,34499.9012.9K → 13.5K0.01%+0.00 pp7(2)told 16 Feb 2023
16 Feb 2023Nikunj DesaiRelativeBuy5.7K₹5.7L99.757.2K → 12.9K0.01%+0.00 pp7(2)told 15 Feb 2023
16 Jan 2021Adimans Technologies LLPPromoterSell9.29L₹13.5Cr145.679.39Cr → 9.30Cr59.32%-0.59 pp7(2)told 14 Jan 2021
16 Jan 2021Adimans Technologies LLPPromoterSell31.67L₹44.3Cr139.939.71Cr → 9.39Cr59.91%-2.02 pp7(2)told 14 Jan 2021
22 Dec 2020Adimans Technologies LLPPromoterSell18.7K₹27.2L145.669.71Cr → 9.71Cr61.93%-0.01 pp7(2)told 22 Dec 2020
22 Dec 2020Adimans Technologies LLPPromoterSell19.75L₹28.9Cr146.299.91Cr → 9.71Cr61.94%-1.26 pp7(2)told 22 Dec 2020
30 Mar 2020Himani Sanjay DhotreEmployeeBuy20.0K₹9.7L48.7013.9K → 33.9K0.02%+0.01 pp7(2)told 28 Mar 2020

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 11 Dec 2024

CSV
12 of 20 deals
By year
DateDealClientQuantityPriceValue
11 Dec 2024Sell · bulkCRONY VYAPAR PVT LTD11.35L299.90₹34.1Cr
11 Dec 2024Buy · bulkCRONY VYAPAR PVT LTD11.16L299.19₹33.4Cr
9 Dec 2024Buy · bulkCRONY VYAPAR PVT LTD13.32L277.86₹37.0Cr
9 Dec 2024Sell · bulkCRONY VYAPAR PVT LTD11.37L277.82₹31.6Cr
5 Mar 2024Buy · bulkCRONY VYAPAR PVT LTD8.70L276.33₹24.1Cr
5 Mar 2024Sell · bulkCRONY VYAPAR PVT LTD8.56L276.77₹23.7Cr
4 Mar 2024Buy · bulkCRONY VYAPAR PVT LTD10.25L267.80₹27.4Cr
4 Mar 2024Sell · bulkCRONY VYAPAR PVT LTD8.67L268.49₹23.3Cr
28 Dec 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP9.25L173.12₹16.0Cr
28 Dec 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP9.25L173.06₹16.0Cr
21 Sept 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP11.72L172.09₹20.2Cr
21 Sept 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP11.72L172.07₹20.2Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Short-term ASM · Stage I · since 19 Nov 2026 — Short-term Additional Surveillance Measure: a sharp move over a few days; a higher margin applies while it lasts.
  • Zero EPS (4 quarters) · since 16 Nov 2026 — Zero EPS over the last four quarters.

Price band: 10% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations651.1654.7523.8789.0682.3716.3708.1652.7719.8851.4677.6507.4
Other income6.17.21.46.75.68.024.88.16.716.418.23.6
Total income657.1661.9525.2795.7688.0724.3732.8660.8726.5867.8695.8510.9
Total expenses723.4708.0597.3750.6663.0684.9691.5630.2736.9820.5745.3591.9
└ Finance costs33.131.031.936.648.842.142.842.345.843.337.140.1
└ Depreciation80.485.070.672.172.079.181.484.184.488.890.790.4
Profit before tax(66.3)(49.2)(77.6)42.127.127.738.730.5(10.4)46.1(51.2)(81.0)
Tax expense(6.7)20.70.09.022.4(15.4)15.3(34.7)2.524.46.7(14.3)
Net profit(59.6)(69.9)(77.6)33.14.643.123.465.3(13.0)21.7(57.9)(66.7)
EPS-3.80-4.46-4.952.110.302.751.494.16-0.831.39-3.69-4.26
Net margin-9.16%-10.68%-14.81%4.19%0.68%6.02%3.31%10.00%-1.80%2.55%-8.54%-13.15%
PBT margin-10.18%-7.51%-14.81%5.34%3.96%3.87%5.46%4.68%-1.45%5.42%-7.56%-15.96%
Tax rate———21.44%82.88%-55.56%39.46%-113.72%—52.87%——

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 13 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets9,453.59,501.19,581.410,180.59,999.211,109.111,923.311,796.1
Current assets1,918.41,963.11,928.22,144.42,200.42,442.62,842.13,013.8
└ Cash & equivalents131.8187.4264.1228.4341.1463.8787.81,009.1
└ Other bank balances57.4209.6149.3163.1166.0151.9203.5196.2
└ Current investments177.075.923.324.725.415.716.216.6
└ Trade receivables589.9472.0461.1706.1665.1655.3672.9470.4
└ Inventories803.8851.7882.9903.9900.21,027.71,019.11,112.8
Total equity5,809.75,770.85,627.55,736.85,831.56,365.06,676.96,671.1
└ Attributable to owners5,809.75,770.85,627.55,736.85,831.56,365.06,676.96,671.1
└ Non-controlling interest————0.00.00.00.0
└ Share capital31.431.431.431.431.431.431.431.4
Borrowings1,824.51,950.61,964.42,164.92,083.92,244.32,775.43,163.7
└ Current777.9904.61,718.81,022.0934.71,078.71,240.51,631.9
└ Non-current1,046.71,046.0245.61,142.91,149.21,165.61,534.91,531.8
Trade payables219.7209.5244.1208.1230.7195.8211.2275.4
Current liabilities1,798.41,882.32,554.72,067.11,924.82,217.52,317.12,721.1
Total liabilities3,643.83,730.33,953.94,443.74,167.64,744.25,246.45,125.0
Net debt1,458.41,477.71,527.81,748.71,551.51,612.81,768.01,941.8
Debt / equity0.310.340.350.380.360.350.420.47
Current ratio1.071.040.751.041.141.101.231.11

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow220.3218.8384.059.3375.2295.2491.5(15.4)
└ Capex(574.1)(169.9)(303.3)(129.8)(216.8)(118.4)(266.0)(99.1)
Free cash flow(353.7)48.980.7(70.5)158.5176.9225.5(114.5)
Investing cash flow(448.5)(210.5)(229.5)(150.1)(192.2)(89.4)(245.3)(80.9)
Financing cash flow249.747.4(22.2)79.6(102.1)(83.1)200.6317.6
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash21.655.7132.3(11.2)77.0122.7446.7221.3

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

DCAL at a glance

  • DCAL closed at ₹115.57 on 20 Nov 2026, -2.50% on the day, -53.6% over one year, 57.9% below its 52-week high of ₹274.3.
  • Delivery was 53.1% of traded quantity on 20 Nov 2026, the 57th percentile of its own 2,249 sessions with a reading (20-session average 50.0%, 1-year average 50.3%).
  • Market capitalisation is ₹1,812 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-7.39).
  • Q2 FY27 results (consolidated, filed 13 Nov 2026): revenue ₹507 crore (-22.3% year on year), net profit ₹-67 crore (-202.2%); the price moved -19.5% on the first session after.
  • Promoters held 59.32% at 30 Sept 2026, unchanged on the previous filing, with 8.39% of promoter shares pledged.
  • Q3 FY27 results are expected between 3 Feb 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE385W01011
SeriesEQ
Listed21 Sept 2017
NSE market cap · 17 Nov 2026₹2,044 Cr
Free-float market cap (NSE)₹831 Cr
Shares outstanding (NSE)15.68Cr
History from21 Sept 2017
Sessions2,268

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.